These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
532 related articles for article (PubMed ID: 20202878)
21. A new assay for fast, reliable CRIM status determination in infantile-onset Pompe disease. Wang Z; Okamoto P; Keutzer J Mol Genet Metab; 2014 Feb; 111(2):92-100. PubMed ID: 24044919 [TBL] [Abstract][Full Text] [Related]
22. Adjunctive albuterol enhances the response to enzyme replacement therapy in late-onset Pompe disease. Koeberl DD; Austin S; Case LE; Smith EC; Buckley AF; Young SP; Bali D; Kishnani PS FASEB J; 2014 May; 28(5):2171-6. PubMed ID: 24443373 [TBL] [Abstract][Full Text] [Related]
23. Assessing the Role of Anti rh-GAA in Modulating Response to ERT in a Late-Onset Pompe Disease Cohort from the Italian GSDII Study Group. Filosto M; Cotti Piccinelli S; Ravaglia S; Servidei S; Moggio M; Musumeci O; Donati MA; Pegoraro E; Di Muzio A; Maggi L; Tonin P; Marrosu G; Sancricca C; Lerario A; Sacchini M; Semplicini C; Bozzoni V; Telese R; Bonanno S; Piras R; Maioli MA; Ricci G; Vercelli L; Galvagni A; Gallo Cassarino S; Caria F; Mongini T; Siciliano G; Padovani A; Toscano A Adv Ther; 2019 May; 36(5):1177-1189. PubMed ID: 30879255 [TBL] [Abstract][Full Text] [Related]
24. Enzyme replacement therapy with alglucosidase alfa in Pompe disease: Clinical experience with rate escalation. Desai AK; Walters CK; Cope HL; Kazi ZB; DeArmey SM; Kishnani PS Mol Genet Metab; 2018 Feb; 123(2):92-96. PubMed ID: 29289479 [TBL] [Abstract][Full Text] [Related]
25. Prognostic factors for late-onset Pompe disease with enzyme replacement therapy: The two sides of low BMI. Ravaglia S; Carlucci A; Danesino C Mol Genet Metab; 2010 Aug; 100(4):388. PubMed ID: 20472481 [No Abstract] [Full Text] [Related]
26. Large variation in effects during 10 years of enzyme therapy in adults with Pompe disease. Harlaar L; Hogrel JY; Perniconi B; Kruijshaar ME; Rizopoulos D; Taouagh N; Canal A; Brusse E; van Doorn PA; van der Ploeg AT; Laforêt P; van der Beek NAME Neurology; 2019 Nov; 93(19):e1756-e1767. PubMed ID: 31619483 [TBL] [Abstract][Full Text] [Related]
27. Pregnancy and associated events in women receiving enzyme replacement therapy for late-onset glycogen storage disease type II (Pompe disease). Rohman PJ; Scott E; Richfield L; Ramaswami U; Hughes DA J Obstet Gynaecol Res; 2016 Oct; 42(10):1263-1271. PubMed ID: 27384519 [TBL] [Abstract][Full Text] [Related]
28. Enzyme replacement therapy and immunotherapy lead to significant functional improvement in two children with Pompe disease: a case report. Castellar-Leones SM; Ortiz-Corredor F; Manrique-Hernández D; Sánchez-Peñarete D; Ruiz-Ospina E; Soto-Peña D; Correa-Arrieta C J Med Case Rep; 2024 Jul; 18(1):328. PubMed ID: 39020349 [TBL] [Abstract][Full Text] [Related]
29. High antibody titer in an adult with Pompe disease affects treatment with alglucosidase alfa. de Vries JM; van der Beek NA; Kroos MA; Ozkan L; van Doorn PA; Richards SM; Sung CC; Brugma JD; Zandbergen AA; van der Ploeg AT; Reuser AJ Mol Genet Metab; 2010 Dec; 101(4):338-45. PubMed ID: 20826098 [TBL] [Abstract][Full Text] [Related]
30. [Pompe disease treated with enzyme replacement therapy in pregnancy]. Grosz Z; Várdi KV; Molnár JM Ideggyogy Sz; 2020 Sep; 73(9-10):339-344. PubMed ID: 33035415 [TBL] [Abstract][Full Text] [Related]
31. Enzyme replacement therapy in severe adult-onset glycogen storage disease type II. Ravaglia S; Danesino C; Pichiecchio A; Repetto A; Poloni GU; Rossi M; Fratino P; Moglia A; Costa A Adv Ther; 2008 Aug; 25(8):820-9. PubMed ID: 18704279 [TBL] [Abstract][Full Text] [Related]
32. Prospective exploratory muscle biopsy, imaging, and functional assessment in patients with late-onset Pompe disease treated with alglucosidase alfa: The EMBASSY Study. van der Ploeg A; Carlier PG; Carlier RY; Kissel JT; Schoser B; Wenninger S; Pestronk A; Barohn RJ; Dimachkie MM; Goker-Alpan O; Mozaffar T; Pena LD; Simmons Z; Straub V; Guglieri M; Young P; Boentert M; Baudin PY; Wens S; Shafi R; Bjartmar C; Thurberg BL Mol Genet Metab; 2016 Sep; 119(1-2):115-23. PubMed ID: 27473031 [TBL] [Abstract][Full Text] [Related]
33. A beta-blocker, propranolol, decreases the efficacy from enzyme replacement therapy in Pompe disease. Han SO; Pope R; Li S; Kishnani PS; Steet R; Koeberl DD Mol Genet Metab; 2016 Feb; 117(2):114-9. PubMed ID: 26454691 [TBL] [Abstract][Full Text] [Related]
34. Effects of short-to-long term enzyme replacement therapy (ERT) on skeletal muscle tissue in late onset Pompe disease (LOPD). Ripolone M; Violano R; Ronchi D; Mondello S; Nascimbeni A; Colombo I; Fagiolari G; Bordoni A; Fortunato F; Lucchini V; Saredi S; Filosto M; Musumeci O; Tonin P; Mongini T; Previtali S; Morandi L; Angelini C; Mora M; Sandri M; Sciacco M; Toscano A; Comi GP; Moggio M Neuropathol Appl Neurobiol; 2018 Aug; 44(5):449-462. PubMed ID: 28574618 [TBL] [Abstract][Full Text] [Related]
35. Brain development in infantile-onset Pompe disease treated by enzyme replacement therapy. Chien YH; Lee NC; Peng SF; Hwu WL Pediatr Res; 2006 Sep; 60(3):349-52. PubMed ID: 16857770 [TBL] [Abstract][Full Text] [Related]
36. Recombinant human acid alpha-glucosidase (rhGAA) in adult patients with severe respiratory failure due to Pompe disease. Orlikowski D; Pellegrini N; Prigent H; Laforêt P; Carlier R; Carlier P; Eymard B; Lofaso F; Annane D Neuromuscul Disord; 2011 Jul; 21(7):477-82. PubMed ID: 21550241 [TBL] [Abstract][Full Text] [Related]
37. Improved efficacy of gene therapy approaches for Pompe disease using a new, immune-deficient GSD-II mouse model. Xu F; Ding E; Liao SX; Migone F; Dai J; Schneider A; Serra D; Chen YT; Amalfitano A Gene Ther; 2004 Nov; 11(21):1590-8. PubMed ID: 15356673 [TBL] [Abstract][Full Text] [Related]
38. Partial phenotypic correction and immune tolerance induction to enzyme replacement therapy after hematopoietic stem cell gene transfer of alpha-glucosidase in Pompe disease. Douillard-Guilloux G; Richard E; Batista L; Caillaud C J Gene Med; 2009 Apr; 11(4):279-87. PubMed ID: 19263466 [TBL] [Abstract][Full Text] [Related]
39. Long-term follow-up of 17 patients with childhood Pompe disease treated with enzyme replacement therapy. van der Meijden JC; Kruijshaar ME; Harlaar L; Rizopoulos D; van der Beek NAME; van der Ploeg AT J Inherit Metab Dis; 2018 Nov; 41(6):1205-1214. PubMed ID: 29556838 [TBL] [Abstract][Full Text] [Related]